KCNA3 and myasthenia gravis: Interestingly, cholinergic transmission at the neuromuscular junction (NMJ) can be boosted via potassium channel blockade with fampridine (4-aminopyridine) and has been clinically indicated in disorders such as myasthenia gravis and multiple sclerosis49.